The CMS and FDA have been actively promoting proposed rule changes, rolling out new programs and adopting new technologies in an effort to advance the US healthcare system and modernize their agencies. From efforts to increase transparency, waivers to experiment, and adoption of Artificial Intelligence, these agencies are taking action. The team discusses some of these activities and what the impact could be to the healthcare industry.
Bonus Episode – Digital and Life Sciences
Vaccine Disease Awareness Strategy
A Global Medical Affairs infectious disease team wanted to understand and leverage key learnings from Disease Awareness pre-launch/launch activities of relevant analog vaccines to inform a global strategy for a vaccine in clinical development. Learn more about how Vynamic approached and delivered this project.
Bonus Episode – The Story of Bainbridge Health
Pivoting Oncology Launch Plans Amid COVID-19
The COVID-19 pandemic has changed how new therapies are commercially launched in the US, and many life sciences manufacturers have had to pivot to ensure patients are able to access medications they need. Learn how Vynamic recently advised two large pharmaceutical companies working within in an alliance on how to pivot their launch planning efforts (both internally and externally) for two oncology indication launches.
Entrepreneurial Methods & Incubating Ideas in Healthcare
Five Success Factors For Launching Healthcare Tech Products
The COVID-19 pandemic has not only driven an increased appetite and need for digital transformation, but also forced healthcare technology companies around the world to rethink how they launch products and find a new normal. View Vynamic's full insight into the five success factors for launching healthcare tech products.
Global Vaccines Strategy: COVID-19 Impact Assessment
The Global Vaccines team of a large pharmaceutical company engaged Vynamic to provide a strategic assessment of the potential impact of COVID-19 on the future landscape of diagnostics and surveillance of respiratory viruses.
Innovations in Healthcare
COVID-19 Business Response – Phase 2: Leading During The Pre-Vaccine Phase
Crafting a Return-to-Workplace strategy is an exercise in continuous change management. Careful and balanced evaluation of external, internal, and personal readiness criteria make for robust, flexible plans. View Vynamic's full insight and guidance into "Phase 2: Leading During The Pre-Vaccine Phase".
Want to learn more? Get in Touch!
Contact our team to learn more about how we can help your needs.